Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AbbVie (ABBV) Q4 2024 Earnings Call Transcript

TheMotleyFool 
0 0 31.01.25
AbbVie (ABBV) Q4 2024 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
 

Image source: The Motley Fool.

(NYSE: ABBV)
Q4 2024 Earnings Call
Jan 31, 2025, 9:00 a.m. ET

Operator

Continue reading


Source Fool.com

AbbVie Inc. Stock

€213.10
0.520%
AbbVie Inc. gained 0.520% compared to yesterday.
The stock is an absolute favorite of our community with 46 Buy predictions and no Sell predictions.
As a result the target price of 228 € shows a slightly positive potential of 6.99% compared to the current price of 213.1 € for AbbVie Inc..
Show more
Like: 0
ABBV
Share

Comments

Not a member yet? Sign up for free!